Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
8.36
-0.10 (-1.18%)
At close: Nov 6, 2026, 4:00 PM EST
8.36
0.00 (-0.06%)
After-hours: Nov 6, 2026, 7:30 PM EST
Harvard Bioscience Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Harvard Bioscience stock has a consensus rating of "Hold" and an average price target of $10.25. The average 1-year stock price forecast is 22.61% higher than the current stock price, while the lowest is $7.50 (-10.29%) and the highest is $13 (+55.50%).
Price Target: $10.25 (+22.61%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Harvard Bioscience stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
89.79M
from 86.55M
Increased by 3.75%
Revenue Next Year
94.70M
from 89.79M
Increased by 5.46%
EPS This Year
-0.38
from -0.20
EPS Next Year
0.65
from -0.38
EPS and Forward PE are based on non-GAAP adjusted numbers.